The President and Chief Executive Officer of Gain Therapeutics is Gene Mack, who leads the clinical-stage biotechnology company in its discovery and development of novel allosteric small molecule therapies. In his executive capacity, he oversees corporate strategy, clinical trial execution—such as programs targeting Parkinson's disease—and financial operations. Under his leadership, the company continues to advance its proprietary platform technology and manage regulatory milestones across international medical and investor platforms.